Commercial Union Life Assurance Company Ltd, Re

Factual and Procedural Background

On 18 September 2009, the Court sanctioned a transfer of insurance business involving several long-established insurance companies, including Company A, Company B, and Company C, into Company D, following a series of mergers and corporate restructurings culminating in the formation of a larger group known as Company E. The transfer was proposed under Part VII of the Financial Services and Markets Act 2000 ("FSMA") as part of a rationalisation and simplification of the corporate structure.

The companies involved had long histories of conducting life assurance business, including "with profits" policies supported by inherited estates. The proposed transfer included a re-attribution of the inherited estates of Company A and Company B, which was a key contentious element. Two schemes were presented for sanction: the Main Scheme, which included the re-attribution, and an Alternative Scheme without it.

The Court’s jurisdiction and the statutory criteria under FSMA were considered, with the main issue being whether it was appropriate in all circumstances to sanction either scheme. The Court’s role was clarified as limited to assessing the overall fairness and appropriateness of the scheme, not to revisit past business conduct or individual policyholder circumstances.

Legal Issues Presented

1. Whether the proposed insurance business transfer scheme qualifies as an "insurance business transfer scheme" under FSMA.
2. Whether the jurisdictional criteria set out in Schedule 12 FSMA have been satisfied.
3. Whether, in all the circumstances, it is appropriate to sanction the Main Scheme or the Alternative Scheme.
4. Whether the re-attribution of inherited estates within the Main Scheme is fair and appropriate to policyholders and shareholders.
5. Whether the Court has jurisdiction to sanction the scheme given regulatory considerations, including consent from relevant EEA regulators.

Arguments of the Parties

Appellant's Arguments

• Some objectors contended that the re-attribution of the inherited estate was improper, arguing that the inherited estate belongs to policyholders and should be distributed accordingly.
• Concerns were raised about the fairness of the Policyholder Incentive Payment ("PIP"), including its amount and the minimum payment structure.
• Objections included allegations that the independent expert's competence and independence were compromised, and that the Policyholder Advocate lacked independence due to funding and operational ties to Company E.
• Certain objectors argued that the scheme failed to adequately protect policyholders’ interests, particularly those who did not participate in the re-attribution or who held cluster policies.
• Claims were made that the inherited estate was being used improperly to subsidise new business or pay shareholder tax.
• Some objectors suggested that the Court should delay sanction due to adverse market conditions or unresolved legal and regulatory issues.
• There were accusations that the process was coercive or rigged, undermining the validity of policyholders' elections regarding the PIP.

Respondent's Arguments

• The independent expert and Company E submitted that the transfer and re-attribution schemes were fair and appropriate, supported by detailed actuarial and financial analysis.
• The Policyholder Advocate, acting independently, negotiated the terms of the PIP, concluding that the offer was substantially beneficial to policyholders compared to their reasonable benefit expectations.
• The Financial Services Authority ("FSA") assessed and supported the Main Scheme as falling within a reasonable range of fair outcomes, considering regulatory principles including Treating Customers Fairly ("TCF").
• Company E maintained that the inherited estate is part of the company’s working capital, not property of policyholders, and that the PIP represents a price paid for policyholders’ relinquishment of future expectations rather than a distribution of profits.
• It was argued that the re-attribution is voluntary, consensual, and distinct from a distribution, with detailed governance arrangements such as a With Profits Committee ("WPC") to protect policyholder interests.
• The Court’s role was limited to assessing overall fairness and appropriateness, without substituting its own commercial judgment for that of the company’s board.

Table of Precedents Cited

Court's Reasoning and Analysis

The Court carefully considered whether the transfer scheme met the statutory criteria under FSMA, focusing on the appropriateness of sanctioning the Main Scheme or the Alternative Scheme. The Court acknowledged its limited role, which is not to revisit past business conduct or individual policyholder grievances, nor to direct company management decisions.

The independent expert’s detailed reports were given significant weight, with the Court accepting the expert’s conclusions that the scheme’s governance arrangements protect policyholder interests, and that no group of policyholders would suffer a significant reduction in security or reasonable benefit expectations. The Court rejected objections alleging incompetence or impropriety by the expert.

The Court considered the role of the Policyholder Advocate, noting her pioneering position and the balanced advice she received. While some objectors challenged her independence and effectiveness, the Court found no substance in these claims and accepted her negotiated offer as beneficial to policyholders.

The Financial Services Authority’s support of the Main Scheme, based on its regulatory objectives and independent assessments, was a key factor. The Court recognized the FSA’s supervisory role and the detailed regulatory framework, including Treating Customers Fairly principles and Conduct of Business Sourcebook provisions governing with-profits business and re-attribution of inherited estates.

The Court analyzed the nature of the inherited estate, explaining it is part of the insurer’s working capital rather than property of policyholders. It differentiated between distributions (unilateral, surplus-based, 90/10 splits) and re-attributions (bilateral, contractual, negotiated payments releasing working capital under conditions). The Court accepted that the Policyholder Incentive Payment is a price for relinquishing future expectations, not a distribution of profits.

The Court addressed numerous objections, including concerns about fairness, the use of the inherited estate to subsidise new business or pay shareholder tax, the level of the PIP, and the timing of the offer. It found that the scheme’s detailed provisions, governance mechanisms, and regulatory oversight adequately mitigate these concerns.

The Court also considered jurisdictional issues related to EEA regulators, specifically the Portuguese regulator, and concluded that the statutory conditions for sanction were met despite ongoing consultations, thereby affirming jurisdiction.

Overall, the Court concluded that the Main Scheme was appropriate to sanction, balancing the interests of all affected parties and respecting the limits of its judicial function.

Holding and Implications

The Court’s final decision was to sanction the Main Scheme, including the transfer of long-term insurance business and the re-attribution of inherited estates, subject to minor jurisdictional conditions being met.

The sanction enables Company E to proceed with the corporate restructuring and capital rationalisation as planned, implementing governance structures to protect policyholder interests and ensure regulatory compliance. Policyholders are given a voluntary choice regarding participation in the re-attribution, with a substantial majority having elected to accept the Policyholder Incentive Payment.

No new legal precedent was established beyond the application of existing principles governing insurance business transfer schemes under FSMA. The decision confirms the Court’s role as one of oversight ensuring fairness and appropriateness without substituting its commercial judgment for that of the company’s board or regulators.